Literature DB >> 16194934

A RANKL-inducible gene Znf216 in osteoclast differentiation.

Akinori Hishiya1, Kyoji Ikeda, Ken Watanabe.   

Abstract

Osteoclasts possess catabolic activity in mineralized tissues and are involved in bone remodeling coordinating with osteoblasts. Although the pathway using receptor and activator of NF-kappa B (RANK) and its ligand, RANKL, is known to be essential for osteoclast differentiation, their precise mechanisms are not fully understood. Using DNA microarray technology, we searched for genes that were up-regulated after RANKL stimulation in the macrophage cell line, RAW264.7 cells. A gene, Znf216, which encodes a zinc-finger protein, was detected among those genes up-regulated after RANKL stimulation. Expression of Znf216 was also induced by other cytokines such as TNFalpha and IL-1beta. Although ectopic expression of full-length ZNF216 abrogated osteoclast differentiation, its truncated forms accelerated it. No significant inhibitory effect on the NF-kappa B pathway was observed, however. These results suggest that ZNF216 is a potent inhibitory factor for osteoclast differentiation and that the mechanism is unlikely due to direct attenuation of the NF-kappa B pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16194934     DOI: 10.1080/10799890500240781

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  7 in total

1.  The protein Zfand5 binds and stabilizes mRNAs with AU-rich elements in their 3'-untranslated regions.

Authors:  Guoan He; Dongxu Sun; Zhiying Ou; Aihao Ding
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  A novel ubiquitin-binding protein ZNF216 functioning in muscle atrophy.

Authors:  Akinori Hishiya; Shun-ichiro Iemura; Tohru Natsume; Shinichi Takayama; Kyoji Ikeda; Ken Watanabe
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

3.  Functional genomic assessment of phosgene-induced acute lung injury in mice.

Authors:  George D Leikauf; Vincent J Concel; Kiflai Bein; Pengyuan Liu; Annerose Berndt; Timothy M Martin; Koustav Ganguly; An Soo Jang; Kelly A Brant; Richard A Dopico; Swapna Upadhyay; Clinton Cario; Y P Peter Di; Louis J Vuga; Emrah Kostem; Eleazar Eskin; Ming You; Naftali Kaminski; Daniel R Prows; Daren L Knoell; James P Fabisiak
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

4.  ZFAND5/ZNF216 is an activator of the 26S proteasome that stimulates overall protein degradation.

Authors:  Donghoon Lee; Shinichi Takayama; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-25       Impact factor: 11.205

5.  Identification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activity.

Authors:  Gabriella Mincione; Maria Carmela Di Marcantonio; Chiara Tarantelli; Luca Savino; Donatella Ponti; Marco Marchisio; Paola Lanuti; Silvia Sancilio; Antonella Calogero; Roberta Di Pietro; Raffaella Muraro
Journal:  Oncotarget       Date:  2016-11-15

6.  ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma.

Authors:  Pei Liu; Yijia Wang; Lingling Duan
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

Review 7.  Mechanisms That Activate 26S Proteasomes and Enhance Protein Degradation.

Authors:  Alfred L Goldberg; Hyoung Tae Kim; Donghoon Lee; Galen Andrew Collins
Journal:  Biomolecules       Date:  2021-05-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.